Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Colorcon
Harvard Business School
McKesson

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR ALITRETINOIN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Alitretinoin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002188 ↗ A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals Phase 2 1969-12-31 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002188 ↗ A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research Phase 2 1969-12-31 The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002439 ↗ A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Ligand Pharmaceuticals N/A 1969-12-31 The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00002439 ↗ A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma Completed Anderson Clinical Research N/A 1969-12-31 The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00124436 ↗ Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis Completed Basilea Pharmaceutica Phase 3 2005-03-01 Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to >75% of the baseline disease severity, will be investigated for response to further treatment with alitretinoin. Also, patients who have responded with mild or moderate disease will be investigated for additional treatment effect after prolongated treatment.
NCT00124475 ↗ Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis Completed Basilea Pharmaceutica Phase 3 2004-12-01 The purpose of the study is to determine the therapeutic effect of alitretinoin, a retinoid, on severe, therapy refractory chronic hand dermatitis.
NCT00309621 ↗ Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis Completed Basilea Pharmaceutica Phase 3 2006-04-01 Patients with severe chronic hand dermatitis, that has not responded to topical treatment, including topical steroids and the avoidance of aggravating factors, will be treated with the oral medication alitretinoin. The study aims to investigate the safety and efficacy of the medication when given over a period of 6 months.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Alitretinoin

Condition Name

Condition Name for Alitretinoin
Intervention Trials
Hand Dermatoses 3
Hand Eczema 3
Chronic Hand Eczema 2
Eczema 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Alitretinoin
Intervention Trials
Eczema 8
Dermatitis 4
Skin Diseases 3
Hand Dermatoses 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Alitretinoin

Trials by Country

Trials by Country for Alitretinoin
Location Trials
United States 32
Germany 11
Canada 6
Netherlands 4
Denmark 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Alitretinoin
Location Trials
California 1
New Hampshire 1
District of Columbia 1
Florida 1
Georgia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Alitretinoin

Clinical Trial Phase

Clinical Trial Phase for Alitretinoin
Clinical Trial Phase Trials
Phase 4 2
Phase 3 9
Phase 2 6
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Alitretinoin
Clinical Trial Phase Trials
Completed 11
Unknown status 3
Recruiting 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Alitretinoin

Sponsor Name

Sponsor Name for Alitretinoin
Sponsor Trials
Basilea Pharmaceutica 6
University Medical Center Groningen 3
Ligand Pharmaceuticals 2
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Alitretinoin
Sponsor Trials
Other 17
Industry 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Colorcon
McKinsey
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.